Firefly Neuroscience Overview
- Year Founded
-
2006
- Status
-
Public
- Employees
-
17
- Stock Symbol
-
AIFF
- Investments
-
2
- Share Price
-
$0.94
- (As of Friday Closing)
Firefly Neuroscience General Information
Description
Firefly Neuroscience Inc is an artificial intelligence company advancing precision neuroscience, applying AI and large-scale electrophysiological data to give clinicians a more complete, objective picture of how an individual patient's brain is functioning. The firm is developing neuroscientific solutions that improve outcomes for patients with mental illnesses and cognitive disorders. It is focused on the commercialization of its Brain Network Analytics (BNA) software platform (the "BNA Platform")and the discovery and clinical development of biomarkers that support outcomes for people suffering from mental illnesses and cognitive disorders. The company has one reportable segment: the BNA platform. The Company derives revenue from North America.
Contact Information
Website
www.fireflyneuro.comCorporate Office
- 1100 Military Road
- Kenmore
- New York, NY 14217
- United States
Corporate Office
- 1100 Military Road
- Kenmore
- New York, NY 14217
- United States
Firefly Neuroscience Timeline
Firefly Neuroscience Stock Performance
As of 13-Nov-2026, Firefly Neuroscience’s stock price is $0.94. Its current market cap is $14.7M with 15.7M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.94 | $0.96 | $0.62 - $3.15 | $14.7M | 15.7M | 2.62M | -$0.45 |
Firefly Neuroscience Financials Summary
As of 30-Sep-2026, Firefly Neuroscience has a trailing 12-month revenue of $2.06M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 14,780 | 7,481 | 21,304 | |
| Revenue | 2,058 | 1,142 | 108 | 498 |
| EBITDA | (7,883) | (19,635) | (10,322) | (2,584) |
| Net Income | (7,947) | (19,882) | (10,460) | (2,603) |
| Total Assets | 15,448 | 10,477 | 4,601 | 2,641 |
| Total Debt | 0 | 0 | 694 | 0 |
Firefly Neuroscience Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Firefly Neuroscience Comparisons
Industry
Financing
Details
Firefly Neuroscience Competitors (10)
One of Firefly Neuroscience’s 10 competitors is Brainify.AI, a Venture Capital-Backed company based in New York, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Brainify.AI | Venture Capital-Backed | New York, NY | ||||
| SPARK Neuro | Venture Capital-Backed | Santa Monica, CA | ||||
| Applied Neuroscience | Corporation | St. Petersburg, FL | ||||
| Beacon Biosignals | Venture Capital-Backed | Boston, MA | ||||
| Evoke Neuroscience. | Formerly VC-backed | New York, NY |
Firefly Neuroscience Signals
Firefly Neuroscience Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Firefly Neuroscience Acquisitions (2)
Firefly Neuroscience’s most recent deal was a Merger/Acquisition with Evoke Neuroscience. for . The deal was made on 30-Apr-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Evoke Neuroscience. | 30-Apr-2025 | Merger/Acquisition | Monitoring Equipment | ||
| WaveDancer | 12-Aug-2024 | Merger/Acquisition | Systems and Information Management |
Firefly Neuroscience ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
25.84 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Health Care IT Services
Subindustry
of 50
Rank
Percentile
Firefly Neuroscience Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Evoke Neuroscience. | New York, NY | 2009 |
Firefly Neuroscience FAQs
-
When was Firefly Neuroscience founded?
Firefly Neuroscience was founded in 2006.
-
Where is Firefly Neuroscience headquartered?
Firefly Neuroscience is headquartered in New York, NY.
-
What is the size of Firefly Neuroscience?
Firefly Neuroscience has 17 total employees.
-
What industry is Firefly Neuroscience in?
Firefly Neuroscience’s primary industry is Decision/Risk Analysis.
-
Is Firefly Neuroscience a private or public company?
Firefly Neuroscience is a Public company.
-
What is Firefly Neuroscience’s stock symbol?
The ticker symbol for Firefly Neuroscience is AIFF.
-
What is the current stock price of Firefly Neuroscience?
As of 13-Nov-2026 the stock price of Firefly Neuroscience is $0.94.
-
What is the current market cap of Firefly Neuroscience?
The current market capitalization of Firefly Neuroscience is $14.7M.
-
What is Firefly Neuroscience’s current revenue?
The trailing twelve month revenue for Firefly Neuroscience is $2.06M.
-
Who are Firefly Neuroscience’s competitors?
Brainify.AI, SPARK Neuro, Applied Neuroscience, Beacon Biosignals, and Evoke Neuroscience. are some of the 10 competitors of Firefly Neuroscience.
-
What is Firefly Neuroscience’s annual earnings per share (EPS)?
Firefly Neuroscience’s EPS for 12 months was -$0.45.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process